Carole Nuechterlein serves as Executive at Aligos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Carole Nuechterlein has executed 4 insider transactions totaling $6.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 25, 2023 involved purchasing 7,933,601 shares valued at $6.0M.
Carole Nuechterlein currently holds 11,025,941 shares of Aligos Therapeutics, Inc. (ALGS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carole Nuechterlein has been a net buyer of ALGS stock. They have purchased $6.0M and sold $0 worth of shares.
Carole Nuechterlein's most recent insider trade was on Oct 25, 2023, when they purchased 7,933,601 shares at $0.76 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 283,550 | $N/A | Discretionary |
| Oct 20, 2020 | ALGS | $0 | Conversion | 2,145,991 | $N/A | Discretionary |